感染疾病诊断市场规模、份额、成长分析（按产品类型、按检测类型、按样本类型、按疾病类型、按技术、按最终用户、按地区）- 行业预测 2025-2032

2023 年感染疾病诊断市场规模价值 226 亿美元，预计将从 2024 年的 243.2 亿美元成长到 2032 年的 436.9 亿美元，预测期内（2025-2032 年）的复合年增长率为 7.6%。

由于老年人口的增加（老年人更容易感染疾病）以及人们对早期诊断的认识不断提高，预计感染疾病诊断市场将会成长。对照护现场的需求，尤其是在流行病期间，进一步推动了这一趋势。到 2022 年，65 岁及以上人口数量预计将达到约 7.79 亿，这凸显了对有效诊断解决方案的需求，而到 2050 年，80 岁及以上人口数量预计将超过 14 亿。然而，儘管许多地区的患者人数众多，但由于监管审查力度加大，严格的核准流程可能会阻碍市场成长，市场仍面临挑战。儘管存在感染成像设备等替代方案，但体外诊断已证实的准确性和成本效益仍然具有很高的优势，确保了其在市场上的主导地位。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 监管分析

感染疾病诊断市场规模（按产品和复合年增长率） (2025-2032)

• 市场概览
• 试剂、套件及耗材
• 装置
• 软体和服务

感染疾病诊断市场规模（按检测类型和复合年增长率） (2025-2032)

• 市场概览
• 实验室测试
• POC 测试

感染疾病诊断市场规模（按样本类型和复合年增长率） (2025-2032)

• 市场概览
• 血液、血清、血浆
• 尿
• 其他样本类型

感染疾病诊断市场规模（按疾病类型和复合年增长率） (2025-2032)

• 市场概览
• 肝炎
  • B型肝炎
  • C型肝炎
  • 其他肝炎疾病
• HIV
• 院内感染
• 蚊媒疾病
• HPV
• 披衣菌感染衣原体
• 淋病
• 结核
• 流感
• 梅毒
• 其他感染疾病

感染疾病诊断市场规模（依技术及复合年增长率） (2025-2032)

• 市场概览
• 免疫诊断
• 临床微生物学
• 聚合酵素链锁反应
• 恒温核酸增幅技术
• DNA定序与次世代定序
• DNA微阵列
• 其他技术

感染疾病诊断市场规模（依最终用户划分）及复合年增长率（2025-2032）

• 市场概览
• 诊断实验室
• 医院和诊所
• 学术研究所
• 其他最终用户

感染疾病诊断市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• F. Hoffmann-La Roche Ltd.（Switzerland）
• Abbott（US）
• bioMerieux（France）
• Siemens Healthineers AG（Germany）
• Danaher（US）
• Thermo Fisher Scientific Inc.（US）
• Hologic, Inc.（US）
• Becton, Dickinson and Company（US）
• Revvity（US）
• Qiagen（Netherlands）
• Seegene Inc.（South Korea）
• QuidelOrtho Corporation（US）
• Grifols, SA（Spain）
• DiaSorin SpA（Italy）
• Bio-Rad Laboratories, Inc.（US）
• Sysmex Corporation（Japan）
• OraSure Technologies（US）
• Co-Diagnostics, Inc.（US）
• Trinity Biotech（Ireland）
• Genetic Signatures Ltd.（Australia）

结论和建议

Infectious Disease Diagnostics Market size was valued at USD 22.6 billion in 2023 and is poised to grow from USD 24.32 billion in 2024 to USD 43.69 billion by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).

The market for infectious disease diagnostics is poised for growth due to a rising elderly population susceptible to infections and increased awareness surrounding early diagnosis. The demand for point-of-care diagnoses, particularly amid ongoing epidemics, further fuels this trend. By 2022, approximately 779 million individuals aged 65 and older emphasized the need for effective diagnostic solutions, with projections anticipating the number of those aged 80 and above will exceed 1.4 billion by 2050. However, increasing regulatory scrutiny poses challenges, as strict approval processes potentially hinder market growth despite the large patient pool in many regions. While alternatives like infectious imaging devices exist, the proven accuracy and cost-effectiveness of in vitro diagnostics remain highly favorable, ensuring their dominance in the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Infectious Disease Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Infectious Disease Diagnostics Market Segments Analysis

Global Infectious Disease Diagnostics Market is segmented by Product, Type of Testing, Sample Type, Disease Type, Technology, End User and region. Based on Product, the market is segmented into Reagents, Kits, And Consumables, Instruments and Software & Services. Based on Type of Testing, the market is segmented into Laboratory Testing and POC Testing. Based on Sample Type, the market is segmented into Blood, Serum, And Plasma, Urine and Other Sample Types. Based on Disease Type, the market is segmented into Hepatitis, HIV, Hospital-Acquired Infections, Mosquito-Borne Diseases, HPV, Chlamydia Trachomatis, Neisseria Gonorrhea, Tuberculosis, Influenza, Syphilis and Other Infectious Diseases. Based on Technology, the market is segmented into Immunodiagnostics,Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarray and Other Technologies. Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals & Clinics, Academic Research Institutes and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Infectious Disease Diagnostics Market

The growing incidence of infectious diseases such as HIV, tuberculosis, hepatitis, and COVID-19 is significantly propelling the demand for advanced diagnostic solutions worldwide. Effective treatment hinges on accurate and timely diagnosis, which is driving innovation in diagnostic technologies, including wearable injectors that integrate these advanced capabilities. Furthermore, the heightened focus on disease surveillance and outbreak monitoring is increasing the need for rapid, accessible diagnostics, thereby fostering market growth. As healthcare systems and organizations recognize the importance of early detection in managing infectious outbreaks, the infectious disease diagnostics market continues to expand in response to these critical healthcare challenges.

Restraints in the Infectious Disease Diagnostics Market

Despite advancements in technology, the prohibitive costs associated with advanced diagnostic tools and wearable injectors continue to pose a significant challenge. In many countries, particularly those classified as low- and middle-income, the affordability and availability of these diagnostic solutions remain major obstacles, hindering their widespread implementation. This financial challenge not only affects the growth of the Infectious Disease Diagnostics Market but also intensifies existing healthcare disparities, especially in regions with limited healthcare resources. Consequently, the inability to access effective diagnostics exacerbates the struggles faced by communities in managing infectious diseases effectively.

Market Trends of the Infectious Disease Diagnostics Market

The infectious disease diagnostics market is experiencing significant growth driven by the surge in Point-of-Care Testing (POCT). This trend is characterized by the decentralization of healthcare delivery, as rapid on-demand analysis and the convenience of portable diagnostic kits become integral to patient care. The ease of use and accessibility of these tests are facilitating increased patient attendance while alleviating pressure on hospitals by enabling outpatient testing. As healthcare systems prioritize efficiency and patient-centric solutions, the demand for innovative POCT solutions is expected to escalate, reshaping the landscape of infectious disease diagnostics and enhancing overall healthcare delivery.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Regulatory Analysis

Global Infectious Disease Diagnostics Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Reagents, Kits, And Consumables
• Instruments
• Software & Services

Global Infectious Disease Diagnostics Market Size by Type of Testing & CAGR (2025-2032)

• Market Overview
• Laboratory Testing
• POC Testing

Global Infectious Disease Diagnostics Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• Blood, Serum, And Plasma
• Urine
• Other Sample Types

Global Infectious Disease Diagnostics Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Hepatitis
  • Hepatitis B
  • Hepatitis C
  • Other Hepatitis Diseases
• HIV
• Hospital-Acquired Infections
• Mosquito-Borne Diseases
• HPV
• Chlamydia Trachomatis
• Neisseria Gonorrhea
• Tuberculosis
• Influenza
• Syphilis
• Other Infectious Diseases

Global Infectious Disease Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Immunodiagnostics
• Clinical Microbiology
• Polymerase Chain Reaction
• Isothermal Nucleic Acid Amplification Technology
• DNA Sequencing & Next-Generation Sequencing
• DNA Microarray
• Other Technologies

Global Infectious Disease Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Diagnostic Laboratories
• Hospitals & Clinics
• Academic Research Institutes
• Other End Users

Global Infectious Disease Diagnostics Market Size & CAGR (2025-2032)

• North America (Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User)
  • US
  • Canada
• Europe (Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Type of Testing, Sample Type, Disease Type, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Co-Diagnostics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genetic Signatures Ltd. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations